Selleck Chemicals supplies over 3,000 inhibitors used in the study of cell signaling pathways. We actively tracks the latest science so our customers can rely on us to be the leading supplier of the newest inhibitors.
Company WebsiteBromhexine is an expectorant/mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus
More Information Supplier PageBromhexine HCl is a medication prescribed for coughs which works by dissolving hard phlegm.
More Information Supplier PageBromisoval (Bromovalerylurea, Isobromyl, Bromaral, BRN 1773255) is a hypnotic and sedative of the bromoureide group with anti-inflammatory effects.
More Information Supplier PageBromocriptine mesylate is a dopamine receptor agonist with a Ki of 12.2 nM for D3 receptor and D2 receptor and a Ki of 1659 nM, 59.7 nM, 1691 nM for D1 receptor, D4 receptor, and D5 receptor, respectively. Bromocriptine mesylate is used in the treatment of Parkinson’s disease, hyperprolactinemia-associated dysfunctions, and acromegaly.
More Information Supplier PageBromophenol blue is an acid phthalein dye, and it is used as a tracking dye for electrophoresis. Bromophenol blue is also used as a pH indicator, with a transition range of pH 3 to 4.6. It helps to detect proteins and nucleic acids (absorbance at 610 nm), particularly when staining living tissues.
More Information Supplier PageBromophenol blue is an acid phthalein dye, and it is used as a tracking dye for electrophoresis. Bromophenol blue is also used as a pH indicator, with a transition range of pH 3 to 4.6. It helps to detect proteins and nucleic acids (absorbance at 610 nm), particularly when staining living tissues.
More Information Supplier PageBromopyruvic acid (3-BP) is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
More Information Supplier PageBromopyruvic acid (3-BP) is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
More Information Supplier PageBromopyruvic acid (3-BP) is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
More Information Supplier PageBromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 μM, 0.29 μM, 0.122 μM and 0.017 μM for BRD2, BRD4, BRD9 and CECR2, respectively.
More Information Supplier PageBromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 μM, 0.29 μM, 0.122 μM and 0.017 μM for BRD2, BRD4, BRD9 and CECR2, respectively.
More Information Supplier PageBrompheniramine hydrogen maleate(Brompheniramine maleate) is a histamine H1 receptors antagonist.
More Information Supplier PageBrompheniramine hydrogen maleate(Brompheniramine maleate) is a histamine H1 receptors antagonist.
More Information Supplier PageBronopol (2-bromo-2-nitropropane-1,3-diol) is antibacterial agent, used as preservative in cosmetic industry.
More Information Supplier PageBrontictuzumab (Anti-NOTCH1) is a monoclonal antibody that targets Notch1 signal. It inhibits tumor cell proliferation and can be used in the research of leukemia and lymphoma. MW :150 KD.
More Information Supplier PageBrontictuzumab (Anti-NOTCH1) is a monoclonal antibody that targets Notch1 signal. It inhibits tumor cell proliferation and can be used in the research of leukemia and lymphoma. MW :150 KD.
More Information Supplier PageBrontictuzumab (Anti-NOTCH1) is a monoclonal antibody that targets Notch1 signal. It inhibits tumor cell proliferation and can be used in the research of leukemia and lymphoma. MW :150 KD.
More Information Supplier PageBroussonetiae Fructus Extract is obtained from Fructus Broussonetiae, significantly increases the expression of immunoglobulin-binding protein, decreases expression levels of PKR-like endoplasmic reticulum kinase and C/EBP homologous protein, and substantially improves learning, memory and spatial recognition dysfunction in Alzheimer’s disease rats.
More Information Supplier PageBrown Rice Extract is extracted from brown Oryza sativa, which has potent antioxidant activities for alleviating the factors for developing heart failure such as hypertension and diabetes mellitus.
More Information Supplier PageBroxaldine (Brobenzoxaldine, AL307) is an antiprotozoal drug and can be used in leprosy.
More Information Supplier PageBroxaldine (Brobenzoxaldine, AL307) is an antiprotozoal drug and can be used in leprosy.
More Information Supplier PageBroxyquinoline(Dibromohydroxyquinoline) is an antiprotozoal agent and able to release oxygen free radicals from the water in mucous membranes.
More Information Supplier PageBroxyquinoline(Dibromohydroxyquinoline) is an antiprotozoal agent and able to release oxygen free radicals from the water in mucous membranes.
More Information Supplier PageBrr2 inhibitor C9 (Brr2 Inhibitor 9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa a group of progressive retinal degenerative disorders.
More Information Supplier PageBrr2 inhibitor C9 (Brr2 Inhibitor 9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa a group of progressive retinal degenerative disorders.
More Information Supplier PageBrucea Javanica Extract is drawed from the fruit of Brucea Javanica, which has demonstrated effective against tumor.
More Information Supplier PageBruceine D, isolated from Brucea javanica (L.) Merr. (Simaroubaceae), shows antineoplastic properties in various human cancers including pancreas, breast, lung, blood, bone, and liver. Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.
More Information Supplier PageBrucine((-)-Brucine), an alkaloid closely related to strychnine, is most commonly found in the Strychnos nux-vomica tree.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
More Information Supplier PageBrucine is an alkaloid that acts as an antagonist at glycine receptors and paralyzes inhibitory neurons.
More Information Supplier PageBrucine is an alkaloid that acts as an antagonist at glycine receptors and paralyzes inhibitory neurons.
More Information Supplier PageBrusatol (NSC 172924), isolated from the fruit of B. javanica, is a NRF2 inhibitor.
More Information Supplier PageBrusatol (NSC 172924), isolated from the fruit of B. javanica, is a NRF2 inhibitor.
More Information Supplier PageBrusatol (NSC 172924), isolated from the fruit of B. javanica, is a NRF2 inhibitor.
More Information Supplier PageBrusatol (NSC 172924), isolated from the fruit of B. javanica, is a NRF2 inhibitor.
More Information Supplier PageBrusatol (NSC 172924), isolated from the fruit of B. javanica, is a NRF2 inhibitor.
More Information Supplier PageBrusatol (NSC 172924), isolated from the fruit of B. javanica, is a NRF2 inhibitor.
More Information Supplier PageBS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.
More Information Supplier PageBS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.
More Information Supplier PageBS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.
More Information Supplier PageBS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.
More Information Supplier PageBSJ-03-123 is a phthalimide-based degrader of cyclin-dependent kinase 6 (CDK6). (PROTAC)
More Information Supplier PageBSJ-03-123 is a phthalimide-based degrader of cyclin-dependent kinase 6 (CDK6). (PROTAC)
More Information Supplier PageBSJ-03-123 is a phthalimide-based degrader of cyclin-dependent kinase 6 (CDK6). (PROTAC)
More Information Supplier PageBSJ-03-123 is a phthalimide-based degrader of cyclin-dependent kinase 6 (CDK6). (PROTAC)
More Information Supplier PageBSJ-4-116 is a specific degrader of cyclin-dependent kinase 12 (CDK12). BSJ-4-116 exhibits potent antiproliferative effects.
More Information Supplier PageBSJ-4-116 is a specific degrader of cyclin-dependent kinase 12 (CDK12). BSJ-4-116 exhibits potent antiproliferative effects.
More Information Supplier PageBSO is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase (γ;-glutamylcysteine synthetase, γ;-GCS) and depletes cellular glutathione levels. The IC50 of BSO on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.
More Information Supplier PageBSO is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase (γ;-glutamylcysteine synthetase, γ;-GCS) and depletes cellular glutathione levels. The IC50 of BSO on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.
More Information Supplier PageBSO is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase (γ;-glutamylcysteine synthetase, γ;-GCS) and depletes cellular glutathione levels. The IC50 of BSO on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.
More Information Supplier PageBSO is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase (γ;-glutamylcysteine synthetase, γ;-GCS) and depletes cellular glutathione levels. The IC50 of BSO on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.
More Information Supplier Page
